Login or sign up
For business

Precision biosciences, inc.

4.2· 10 reviews
Average ratingGreat
4.2/ 5

Based on 10 reviews

540%
440%
320%
20%
10%

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Precision biosciences, inc.

Precision BioSciences utilizes its proprietary ARCUS Genome Editing method to overcome cancers, cure genetic diseases, and enable development of safer food.

Precision BioSciences, Inc. is a biotechnology company that specializes in genome editing. The company was founded in 2006 and is headquartered in Durham, North Carolina. Precision BioSciences has developed a proprietary genome editing method called ARCUS that enables precise and efficient gene editing.

The ARCUS Genome Editing method is based on the use of a type of enzyme called a homing endonuclease. Homing endonucleases are naturally occurring enzymes that can recognize and cut specific DNA sequences with high precision. Precision BioSciences has engineered these enzymes to create highly specific nucleases that can be used to edit genes.

One of the key advantages of the ARCUS Genome Editing method is its ability to target multiple sites within the genome simultaneously. This allows for more precise and efficient gene editing than other methods currently available.

Precision BioSciences' technology has numerous potential applications across a wide range of industries, including healthcare, agriculture, and industrial biotechnology.

In healthcare, Precision BioSciences is focused on developing therapies for genetic diseases and cancer. The company's lead product candidate is PBCAR0191, an allogeneic CAR T cell therapy for treating relapsed or refractory non-Hodgkin lymphoma (NHL) and B-cell acute lymphoblastic leukemia (B-ALL). PBCAR0191 uses Precision BioSciences' proprietary ARCUS Genome Editing technology to precisely target cancer cells while sparing healthy cells.

Precision BioSciences also has several preclinical programs focused on developing therapies for genetic diseases such as sickle cell disease and Duchenne muscular dystrophy (DMD). These programs utilize the company's ARCUS Genome Editing technology to correct or replace defective genes responsible for these diseases.

In agriculture, Precision BioSciences is working to develop crops with improved traits such as increased yield or resistance to pests or environmental stressors. The company's technology allows for precise modification of plant genomes without introducing foreign DNA into the plant's genome.

Precision BioSciences' industrial biotechnology program focuses on developing enzymes for use in various industrial processes such as biofuels production or chemical synthesis. The company's proprietary enzyme engineering platform allows for rapid optimization of enzyme performance through directed evolution.

Overall, Precision Biosciences' innovative approach to genome editing using its proprietary ARCUS Genome Editing method holds great promise across multiple industries including healthcare, agriculture, and industrial biotechnology. With its focus on precision gene editing techniques that enable safer food development while overcoming cancers & curing genetic diseases; it stands out among other companies working in this field today!

Address
302 east pettigrew street
Categories
Biotechnology